パクリタキセル、ドセタキセル、カバジタキセルなどの製剤を含むタキサン系抗腫瘍薬は、乳がん、肺がん、卵巣がん、前立腺がんなどのがんと闘うために使用される化学療法剤の重要なクラスです。タキサンは、微小管を安定化し、細胞分裂を阻害することで、急速に分裂するがん細胞を効果的に標的とするため、腫瘍治療計画の主力となっています。この市場は、研究開発費が高く、規制要件が厳しく、標的薬や免疫療法との併用療法が重視される傾向にあるダイナミックな腫瘍医薬品セクターで展開されています。タキサンは有効性で知られていますが、神経障害、好中球減少症、脱毛症などの副作用が使用を阻み、患者の転帰と手頃な価格を改善するために、デリバリーシステムやバイオシミラーの革新が求められています。
世界のタキサン系抗腫瘍薬市場は、2025年には80億〜90億米ドルの規模に達すると推定されています。2025年から2030年にかけて5.0%〜6.5%の年平均成長率（CAGR）で成長し、2030年までに約105億〜120億米ドルに達すると予測されています。この成長は、がん罹患率の増加、併用療法の適用範囲の拡大、ジェネリック医薬品やバイオシミラー製品の拡大によって推進されています。
北アメリカは35〜40%のシェアを占め、5.5〜6.5%で成長しています。アメリカは先進的な腫瘍治療とブランドタキサンの採用率の高さでリードしており、個別化医療への傾向が見られます。カナダは安定した需要でこれに追随しています。ヨーロッパは25〜30%を占め、4.5〜5.5%で成長しています。ドイツとイギリスは堅牢な医療システムで使用を促進し、費用対効果の高いジェネリック医薬品に重点を置いています。アジア太平洋地域は25〜30%を占め、8.0〜9.5%で成長しています。中国とインドは、がん罹患率の上昇と現地製造により急速に拡大しており、手頃な価格のオプションへの傾向が見られます。世界のその他の地域は10〜15%で、6.0〜7.0%で成長しており、ブラジルはジェネリック医薬品へのアクセスを重視しています。
乳がんは35〜40%を占め、6.0〜7.0%で増加しており、パクリタキセルとドセタキセルの広範な使用と補助療法の傾向が牽引しています。胃がんは15〜20%を占め、5.5〜6.5%で増加しており、進行した症例でのドセタキセルの使用が増加しています。卵巣がんは10〜15%を占め、6.5〜7.5%で増加しており、パクリタキセルの併用に焦点が当てられています。肺がんは10〜15%を占め、6.0〜7.0%で増加しており、NSCLC治療の傾向が牽引しています。精巣がんは5〜10%を占め、5.0〜6.0%で増加しており、ニッチな用途があります。前立腺がんは5〜10%を占め、6.5〜7.5%で増加しており、転移症例でのカバジタキセルが牽引しています。その他のがんは増加率が一定ではありません。
パクリタキセルは45〜50%を占め、5.5〜6.5%の成長率で、幅広い効能が評価され、ナノ製剤のトレンドが見られます。ドセタキセルは35〜40%を占め、6.0〜7.0%の成長率で、併用療法のトレンドが見られます。カバジタキセルは10〜15%を占め、7.0〜8.5%の成長率で、耐性がんに焦点を当てています。その他のタキサンは、新たな研究により5.0〜6.0%の成長率が見られます。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Taxane Antineoplastic Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Taxane Antineoplastic Drug Market in North America (2020-2030)
8.1 Taxane Antineoplastic Drug Market Size
8.2 Taxane Antineoplastic Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Taxane Antineoplastic Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Taxane Antineoplastic Drug Market in South America (2020-2030)
9.1 Taxane Antineoplastic Drug Market Size
9.2 Taxane Antineoplastic Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Taxane Antineoplastic Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Taxane Antineoplastic Drug Market in Asia & Pacific (2020-2030)
10.1 Taxane Antineoplastic Drug Market Size
10.2 Taxane Antineoplastic Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Taxane Antineoplastic Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Taxane Antineoplastic Drug Market in Europe (2020-2030)
11.1 Taxane Antineoplastic Drug Market Size
11.2 Taxane Antineoplastic Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Taxane Antineoplastic Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Taxane Antineoplastic Drug Market in MEA (2020-2030)
12.1 Taxane Antineoplastic Drug Market Size
12.2 Taxane Antineoplastic Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Taxane Antineoplastic Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Taxane Antineoplastic Drug Market (2020-2025)
13.1 Taxane Antineoplastic Drug Market Size
13.2 Taxane Antineoplastic Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Taxane Antineoplastic Drug Market Size by Type
Chapter 14 Global Taxane Antineoplastic Drug Market Forecast (2025-2030)
14.1 Taxane Antineoplastic Drug Market Size Forecast
14.2 Taxane Antineoplastic Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Taxane Antineoplastic Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Taxane Antineoplastic Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Sanofi
15.2.1 Company Profile
15.2.2 Main Business and Taxane Antineoplastic Drug Information
15.2.3 SWOT Analysis of Sanofi
15.2.4 Sanofi Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sun Pharma
15.3.1 Company Profile
15.3.2 Main Business and Taxane Antineoplastic Drug Information
15.3.3 SWOT Analysis of Sun Pharma
15.3.4 Sun Pharma Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Bristol-Myers Squibb
15.4.1 Company Profile
15.4.2 Main Business and Taxane Antineoplastic Drug Information
15.4.3 SWOT Analysis of Bristol-Myers Squibb
15.4.4 Bristol-Myers Squibb Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Qilu Pharmaceutical
15.5.1 Company Profile
15.5.2 Main Business and Taxane Antineoplastic Drug Information
15.5.3 SWOT Analysis of Qilu Pharmaceutical
15.5.4 Qilu Pharmaceutical Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Fuxing Medicine
15.6.1 Company Profile
15.6.2 Main Business and Taxane Antineoplastic Drug Information
15.6.3 SWOT Analysis of Fuxing Medicine
15.6.4 Fuxing Medicine Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Yuekang Pharmaceutical
15.7.1 Company Profile
15.7.2 Main Business and Taxane Antineoplastic Drug Information
15.7.3 SWOT Analysis of Yuekang Pharmaceutical
15.7.4 Yuekang Pharmaceutical Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Hengrui Medicine
15.8.1 Company Profile
15.8.2 Main Business and Taxane Antineoplastic Drug Information
15.8.3 SWOT Analysis of Hengrui Medicine
15.8.4 Hengrui Medicine Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 Huiyu Pharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Taxane Antineoplastic Drug Information
15.9.3 SWOT Analysis of Huiyu Pharmaceutical
15.9.4 Huiyu Pharmaceutical Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.10 Zhendong Pharmaceutical
15.10.1 Company Profile
15.10.2 Main Business and Taxane Antineoplastic Drug Information
15.10.3 SWOT Analysis of Zhendong Pharmaceutical
15.10.4 Zhendong Pharmaceutical Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.11 Teva Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Taxane Antineoplastic Drug Information
15.11.3 SWOT Analysis of Teva Pharmaceutical
15.11.4 Teva Pharmaceutical Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.12 Panacea Biotec
15.12.1 Company Profile
15.12.2 Main Business and Taxane Antineoplastic Drug Information
15.12.3 SWOT Analysis of Panacea Biotec
15.12.4 Panacea Biotec Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.13 Viatris
15.13.1 Company Profile
15.13.2 Main Business and Taxane Antineoplastic Drug Information
15.13.3 SWOT Analysis of Viatris
15.13.4 Viatris Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.14 American Regent
15.14.1 Company Profile
15.14.2 Main Business and Taxane Antineoplastic Drug Information
15.14.3 SWOT Analysis of American Regent
15.14.4 American Regent Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.15 Sterimax
15.15.1 Company Profile
15.15.2 Main Business and Taxane Antineoplastic Drug Information
15.15.3 SWOT Analysis of Sterimax
15.15.4 Sterimax Taxane Antineoplastic Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Taxane Antineoplastic Drug Report
Table Data Sources of Taxane Antineoplastic Drug Report
Table Major Assumptions of Taxane Antineoplastic Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Taxane Antineoplastic Drug Picture
Table Taxane Antineoplastic Drug Classification
Table Taxane Antineoplastic Drug Applications
Table Drivers of Taxane Antineoplastic Drug Market
Table Restraints of Taxane Antineoplastic Drug Market
Table Opportunities of Taxane Antineoplastic Drug Market
Table Threats of Taxane Antineoplastic Drug Market
Table Covid-19 Impact For Taxane Antineoplastic Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Taxane Antineoplastic Drug
Table Cost Structure Analysis of Taxane Antineoplastic Drug
Table Key End Users
Table Latest News of Taxane Antineoplastic Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Taxane Antineoplastic Drug Market
Table Policy of Taxane Antineoplastic Drug Market
Table 2020-2030 North America Taxane Antineoplastic Drug Market Size
Figure 2020-2030 North America Taxane Antineoplastic Drug Market Size and CAGR
Table 2020-2030 North America Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 North America Taxane Antineoplastic Drug Key Players Revenue
Table 2020-2025 North America Taxane Antineoplastic Drug Key Players Market Share
Table 2020-2030 North America Taxane Antineoplastic Drug Market Size by Type
Table 2020-2030 United States Taxane Antineoplastic Drug Market Size
Table 2020-2030 Canada Taxane Antineoplastic Drug Market Size
Table 2020-2030 Mexico Taxane Antineoplastic Drug Market Size
Table 2020-2030 South America Taxane Antineoplastic Drug Market Size
Figure 2020-2030 South America Taxane Antineoplastic Drug Market Size and CAGR
Table 2020-2030 South America Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 South America Taxane Antineoplastic Drug Key Players Revenue
Table 2020-2025 South America Taxane Antineoplastic Drug Key Players Market Share
Table 2020-2030 South America Taxane Antineoplastic Drug Market Size by Type
Table 2020-2030 Brazil Taxane Antineoplastic Drug Market Size
Table 2020-2030 Argentina Taxane Antineoplastic Drug Market Size
Table 2020-2030 Chile Taxane Antineoplastic Drug Market Size
Table 2020-2030 Peru Taxane Antineoplastic Drug Market Size
Table 2020-2030 Asia & Pacific Taxane Antineoplastic Drug Market Size
Figure 2020-2030 Asia & Pacific Taxane Antineoplastic Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 Asia & Pacific Taxane Antineoplastic Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Taxane Antineoplastic Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Taxane Antineoplastic Drug Market Size by Type
Table 2020-2030 China Taxane Antineoplastic Drug Market Size
Table 2020-2030 India Taxane Antineoplastic Drug Market Size
Table 2020-2030 Japan Taxane Antineoplastic Drug Market Size
Table 2020-2030 South Korea Taxane Antineoplastic Drug Market Size
Table 2020-2030 Southeast Asia Taxane Antineoplastic Drug Market Size
Table 2020-2030 Australia Taxane Antineoplastic Drug Market Size
Table 2020-2030 Europe Taxane Antineoplastic Drug Market Size
Figure 2020-2030 Europe Taxane Antineoplastic Drug Market Size and CAGR
Table 2020-2030 Europe Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 Europe Taxane Antineoplastic Drug Key Players Revenue
Table 2020-2025 Europe Taxane Antineoplastic Drug Key Players Market Share
Table 2020-2030 Europe Taxane Antineoplastic Drug Market Size by Type
Table 2020-2030 Germany Taxane Antineoplastic Drug Market Size
Table 2020-2030 France Taxane Antineoplastic Drug Market Size
Table 2020-2030 United Kingdom Taxane Antineoplastic Drug Market Size
Table 2020-2030 Italy Taxane Antineoplastic Drug Market Size
Table 2020-2030 Spain Taxane Antineoplastic Drug Market Size
Table 2020-2030 Belgium Taxane Antineoplastic Drug Market Size
Table 2020-2030 Netherlands Taxane Antineoplastic Drug Market Size
Table 2020-2030 Austria Taxane Antineoplastic Drug Market Size
Table 2020-2030 Poland Taxane Antineoplastic Drug Market Size
Table 2020-2030 Russia Taxane Antineoplastic Drug Market Size
Table 2020-2030 MEA Taxane Antineoplastic Drug Market Size
Figure 2020-2030 MEA Taxane Antineoplastic Drug Market Size and CAGR
Table 2020-2030 MEA Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 MEA Taxane Antineoplastic Drug Key Players Revenue
Table 2020-2025 MEA Taxane Antineoplastic Drug Key Players Market Share
Table 2020-2030 MEA Taxane Antineoplastic Drug Market Size by Type
Table 2020-2030 Egypt Taxane Antineoplastic Drug Market Size
Table 2020-2030 Israel Taxane Antineoplastic Drug Market Size
Table 2020-2030 South Africa Taxane Antineoplastic Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Taxane Antineoplastic Drug Market Size
Table 2020-2030 Turkey Taxane Antineoplastic Drug Market Size
Table 2020-2025 Global Taxane Antineoplastic Drug Market Size by Region
Table 2020-2025 Global Taxane Antineoplastic Drug Market Size Share by Region
Table 2020-2025 Global Taxane Antineoplastic Drug Market Size by Application
Table 2020-2025 Global Taxane Antineoplastic Drug Market Share by Application
Table 2020-2025 Global Taxane Antineoplastic Drug Key Vendors Revenue
Figure 2020-2025 Global Taxane Antineoplastic Drug Market Size and Growth Rate
Table 2020-2025 Global Taxane Antineoplastic Drug Key Vendors Market Share
Table 2020-2025 Global Taxane Antineoplastic Drug Market Size by Type
Table 2020-2025 Global Taxane Antineoplastic Drug Market Share by Type
Table 2025-2030 Global Taxane Antineoplastic Drug Market Size by Region
Table 2025-2030 Global Taxane Antineoplastic Drug Market Size Share by Region
Table 2025-2030 Global Taxane Antineoplastic Drug Market Size by Application
Table 2025-2030 Global Taxane Antineoplastic Drug Market Share by Application
Table 2025-2030 Global Taxane Antineoplastic Drug Key Vendors Revenue
Figure 2025-2030 Global Taxane Antineoplastic Drug Market Size and Growth Rate
Table 2025-2030 Global Taxane Antineoplastic Drug Key Vendors Market Share
Table 2025-2030 Global Taxane Antineoplastic Drug Market Size by Type
Table 2025-2030 Taxane Antineoplastic Drug Global Market Share by Type
